Trial intelligence / Profile preview

Feasibility study of stepped pain medication plus exercise therapy for severe knee osteoarthritis pain

NL-OMON20296Active, not recruiting

Sponsor
Reade
Start
Jul 2013
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of acetaminophen, caffeine and corticosteroids in knee osteoarthritis (OA), sponsored by Reade. Primary endpoints: Feasibility of participation in STABILO exercise therapy and Activity limitations. Started Jul 2013; status: active, not recruiting.

02

Drugs

acetaminophencaffeinecorticosteroids
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NL-OMON20296.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20296.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call